Immunome

Develops targeted cancer therapies and antibody-drug conjugates.

BiotechnologyPharmaceuticals immunome.com ↗

Company facts

Founded
2006
Employees
168
Headquarters
United States
Type
Public
Listed
NASDAQ: IMNM
Subsidiaries
MorphImmune